Investigating blood biomarkers for Alzheimer's disease and related dementias
Core F: Biomarker Core
This study is looking for new blood tests that can help doctors better diagnose and treat Alzheimer's disease and similar conditions, and if you're a patient, you might have the chance to take part in this exciting research!
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10883740 on NIH RePORTER |
What this research studies
This research focuses on the development and validation of blood biomarkers that can improve the diagnosis and treatment of Alzheimer's disease and related dementias. By utilizing advanced techniques such as ultrasensitive ELISA and quantitative mass spectrometry, the Biomarker Core aims to identify both established and novel biomarkers in blood samples. The research will integrate these biomarkers with clinical measures to enhance understanding of the disease and support precision medicine approaches. Patients may have the opportunity to contribute to this innovative research through participation in clinical studies.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with Alzheimer's disease or related dementias, as well as those at risk for these conditions.
Not a fit: Patients with non-Alzheimer's related cognitive impairments or those without any cognitive issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment options for patients with Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown promise in using blood biomarkers for Alzheimer's diagnosis, indicating that this approach has potential for significant advancements.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Kanaan, Nicholas M — University of Michigan at Ann Arbor
- Study coordinator: Kanaan, Nicholas M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.